As our nation deals with the unprecedented effects of coronavirus, impacts to public events, work routines, commerce, and general human interaction are occurring in ways we may never have imagined. Many of the events listed here have altered plans and we encourage you to visit their websites for the latest information. From our team at CSI to you, your families, friends, and coworkers, please accept our sincere wishes for good health, safety, and a resumption of activities as soon as possible. We will get through this together but in the meantime please know that we are still available to you, so please do not hesitate to reach out.
CBI’s 5th Annual Bio/Pharmaceutical Product Launch Summit
October 28, 2019 - October 29, 2019
In an increasingly complex healthcare landscape, it is more important than ever to have an early product launch plan for your drug. Whether you are a pre-commercial biotech or an established pharmaceutical company, you’ll face many of the same challenges as you prepare the market, prepare your organization and prepare your product for a successful launch.
Join us for CBI’s 5th Annual Bio/Pharmaceutical Product Launch Summit and analyze each necessary step to innovatively plan for a new product launch. Identify best practices, KPIs and “how to” tactics for immediate implementation.
Specialty Therapeutics — Key Components for Success in an Orphan Product Launch
On Tuesday, October 29 at 9:15 a.m., Richard H. Williams, Senior Vice President at CSI Specialty Group, will present a case study on “Key Components for Success in an Orphan Product Launch”. Some key points include:
- The critical stages in launch planning and common obstacles
- Specific challenges for a rare/orphan drug product launch
- Ensure launch readiness through cross-functional collaboration
- Utilize relationships to help navigate approval pathways
- Who do you need to partner with to be successful?
- The importance of talking to payer groups ahead of time